iBio (IBIO) Research & Development (2010 - 2026)

iBio (IBIO) has reported Research & Development for 17 consecutive years, with $8.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 165.48% year-over-year to $8.6 million in Q2 2026; TTM through Jun 2026 was $19.6 million, a 136.32% increase from a year earlier, with the FY2026 full-year figure at $19.6 million, up 136.32% from the prior year.
• Research & Development was $8.6 million for Q2 2026 at iBio, up from $3.3 million in the prior quarter.
• Over five years, Research & Development peaked at $8.6 million in Q2 2026 and troughed at $904000.0 in Q1 2024.
• A 5-year average of $2.8 million and a median of $2.6 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development slumped 65.81% in 2024 and soared 182.81% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $2.8 million in 2022, then sank by 44.76% to $1.5 million in 2023, then advanced by 22.28% to $1.9 million in 2024, then jumped by 128.02% to $4.3 million in 2025, then surged by 99.98% to $8.6 million in 2026.
• The last three Research & Development figures came in at $8.6 million (Q2 2026), $3.3 million (Q1 2026), and $4.3 million (Q4 2025), per Business Quant data.